All of the indications surrounding Leronlimab ar
Post# of 148279
Why not get this BLA submitted, watch the stock rip, PR debt financing deal, continue watching stock rip, up-list to NASDAQ/NYSE exchange, stock continues to rip....THEN PR all the (well-written, well-thought out, clear and substantive) updates the company can dream up to a much wider and deeper pockets audience. I love all the updates and appreciated all of the communication, but it's kind of like preaching to the choir at this point...
Re: coronavirus. This is one of many common cold viruses (not commonly tested for) that some suspect has been engineered to be more virulent and contagious. Once infected one's own immune response is what creates the destruction in the patient's lungs in an acute respiratory distress syndrome (ARDS)-like picture. I personally think anti-virals are not the way to go but a drug that cant temper the immune response and prevent vast pneumocyte destruction would be a better alternative. Anyone know of such a drug candidate?